MS-DRG 319Surgical
Other Endovascular Cardiac Valve Procedures with MCC
Major Diagnostic Category 05·Grouped by procedure·FY 2027
MS-DRG 319 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) with a Major Complication or Comorbidity (MCC). For FY 2027 it carries a relative weight of 4.2591 with a geometric mean length of stay of 7.1 days and an arithmetic mean of 9.9 days. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Advertisements
FY 2027 payment data
From Table 5 of the FY 2027 IPPS Final Rule (CMS).
- Relative weight:
- 4.2591 (payment multiplier vs. the average case (1.0))
- Geometric mean stay:
- 7.1 days (used for transfer payments)
- Average stay:
- 9.9 days (arithmetic mean)
- Post-acute transfer policy:
- No (not subject to it)
Same condition, other severity levels
CMS splits one condition into separate DRGs by how sick the patient is. With MCC pays more than with CC, which pays more than without CC/MCC.
| DRG | Title | Relative weight | Mean stay |
|---|---|---|---|
| 319 | Other Endovascular Cardiac Valve Procedures with MCC (this page) | 4.2591 | 7.1 days |
| 320 | Other Endovascular Cardiac Valve Procedures without MCC | 2.1648 | 1.9 days |
Procedure codes (42)
ICD-10-PCS procedures that can group a stay to DRG 319.
- 025F3ZZDestruction of Aortic Valve, Percutaneous Approach
- 025G3ZZDestruction of Mitral Valve, Percutaneous Approach
- 025H3ZZDestruction of Pulmonary Valve, Percutaneous Approach
- 025J3ZZDestruction of Tricuspid Valve, Percutaneous Approach
- 027F0ZZDilation of Aortic Valve, Open Approach
- 027G0ZZDilation of Mitral Valve, Open Approach
- 027H0ZZDilation of Pulmonary Valve, Open Approach
- 027J0ZZDilation of Tricuspid Valve, Open Approach
- 028F3Z0Division of Aortic Valve, Percutaneous Approach, Native Leaflet
- 028F3Z1Division of Aortic Valve, Percutaneous Approach, Prosthetic Leaflet
- 028G3Z0Division of Mitral Valve, Percutaneous Approach, Native Leaflet
- 028G3Z1Division of Mitral Valve, Percutaneous Approach, Prosthetic Leaflet
- 02BF3ZZExcision of Aortic Valve, Percutaneous Approach
- 02BG3ZZExcision of Mitral Valve, Percutaneous Approach
- 02BH3ZZExcision of Pulmonary Valve, Percutaneous Approach
- 02BJ3ZZExcision of Tricuspid Valve, Percutaneous Approach
- 02QF3ZJRepair Aortic Valve created from Truncal Valve, Percutaneous Approach
- 02QF3ZZRepair Aortic Valve, Percutaneous Approach
- 02QG3ZERepair Mitral Valve created from Left Atrioventricular Valve, Percutaneous Approach
- 02QG3ZZRepair Mitral Valve, Percutaneous Approach
- 02QH3ZZRepair Pulmonary Valve, Percutaneous Approach
- 02QJ3ZGRepair Tricuspid Valve created from Right Atrioventricular Valve, Percutaneous Approach
- 02QJ3ZZRepair Tricuspid Valve, Percutaneous Approach
- 02TH3ZZResection of Pulmonary Valve, Percutaneous Approach
- 02VG3ZZRestriction of Mitral Valve, Percutaneous Approach
- 02WF38ZRevision of Zooplastic Tissue in Aortic Valve, Percutaneous Approach
- 02WF3JZRevision of Synthetic Substitute in Aortic Valve, Percutaneous Approach
- 02WF3KZRevision of Nonautologous Tissue Substitute in Aortic Valve, Percutaneous Approach
- 02WG37ZRevision of Autologous Tissue Substitute in Mitral Valve, Percutaneous Approach
- 02WG38ZRevision of Zooplastic Tissue in Mitral Valve, Percutaneous Approach
- 02WG3JZRevision of Synthetic Substitute in Mitral Valve, Percutaneous Approach
- 02WG3KZRevision of Nonautologous Tissue Substitute in Mitral Valve, Percutaneous Approach
- 02WH37ZRevision of Autologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach
- 02WH38ZRevision of Zooplastic Tissue in Pulmonary Valve, Percutaneous Approach
- 02WH3JZRevision of Synthetic Substitute in Pulmonary Valve, Percutaneous Approach
- 02WH3KZRevision of Nonautologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach
- 02WJ37ZRevision of Autologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach
- 02WJ38ZRevision of Zooplastic Tissue in Tricuspid Valve, Percutaneous Approach
- 02WJ3JZRevision of Synthetic Substitute in Tricuspid Valve, Percutaneous Approach
- 02WJ3KZRevision of Nonautologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach
- X28F3VADivision of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10
- X28F3WBDivision of Aortic Valve using Leaflet Laceration, Radiofrequency Energy, Percutaneous Approach, New Technology Group 11